Tuberc Respir Dis.
2005 Jul;59(1):62-68.
Clinical Experience of Silicone Airway Stent in the Management of Benign Tracheobronchial Stenosis
- Affiliations
-
- 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Seoul, Korea. hjkim@smc.samsung.co.kr
Abstract
-
BACKGROUND: The clinical results of a Natural stent in patients with a benign tracheobronchial stenosis were examined by comparing the clinical outcomes and complications of those patients who underwent Dumon and Natural stenting in the management of benign airway stenosis.
METHODS
The medical records of 94 patients (39 Dumon and 55 Natural stent) with a benign tracheobronchial stenosis were reviewed and analyzed.
RESULTS
Post-tuberculous stenosis was the leading indication for airway stenting (74%), which was followed by post-intubation stenosis (21%). After intervention, the dyspnea had improved among those patients who underwent Dumon (90%) and Natural (86%) stenting. After stabilizing the dyspnea, the stent could be successfully removed in half of the patients who underwent both Dumon (54%) and Natural (49%) stenting. During the 42 month follow-up period, the complication rate was similar in those patients who underwent Dumon and Natural stenting: migration (46% vs 53%), granulation tissue formation (36% vs 49%), mucostasis (21% vs 16%) and restenosis (51% vs 36%).
CONCLUSION
The clinical results of Natural airway stent was similar to those of Dumon stent in the management of benign tracheobronchial stenosis.